Best Income Stocks to Buy for November 21st

Photo of author

By Ronald Tech

Here is one stock with buy rank and strong income characteristics for investors to consider today, November 21:

Alpine Income Property Trust, Inc. PINE: This real estate investment trust has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% the last 60 days.

Alpine Income Property Trust, Inc. Price and Consensus

Alpine Income Property Trust, Inc. Price and Consensus

Alpine Income Property Trust, Inc. price-consensus-chart | Alpine Income Property Trust, Inc. Quote

This Zacks Rank #1 company has a dividend yield of 6.3%, compared with the industry average of 4.4%.

Alpine Income Property Trust, Inc. Dividend Yield (TTM)

Alpine Income Property Trust, Inc. Dividend Yield (TTM)

Alpine Income Property Trust, Inc. dividend-yield-ttm | Alpine Income Property Trust, Inc. Quote

See the full list of top ranked stocks here.

 

Find more top income stocks with some of our great premium screens.

Research Chief Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 5 Stocks Set to Double. Click to get this free report

See also  The Bullish Surge in Copper Prices: A Promising Outlook for American Eagle Gold (OTC:AMEGF) and Sprott Junior Copper Miners ETF (NASDAQ:COPJ)

Alpine Income Property Trust, Inc. (PINE) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research